ASSC researchers secure NHMRC funding

Skin and skin cancer researchers across The University of Queensland and QIMR Berghofer Medical Research Institute have been successful in the latest round of National Health and Medical Research Council (NHMRC) funding.

QIMR Berghofer’s Deputy Director and ASSC co-lead Professor David Whiteman, said that the success of the recent round of funding shows the strength of skin and skin cancer researchers in Brisbane.

“It demonstrated that our research is truly world class and is a vote of confidence from the research community.”

“This funding will help to ensure the patient outcomes are continued to be improved for Australians with skin diseases and skin cancer.”

A summary of the ASSC members receiving awards are below:

Grant Type CIA Name Grant Title Institution Total
Career Development Fellowships A/Pr Michele Teng Broadening the Efficacy of Cancer Immunotherapies QIMR Berghofer $483,404
Research Fellowships *A/Pr Stuart Macgregor Translating the genetic determinants of glaucoma QIMR Berghofer $649,175
Research Fellowships Dr Katja Fischer Translating Molecular Research into Clinical Applications to Control Scabies QIMR Berghofer $724,175
Research Fellowships Prof David Whiteman Cancer Prevention and Control QIMR Berghofer $888,270
Early Career Fellowships Dr Aideen McInerney-Leo Identifying genes causing melanoma and modifying the phenotype and exploring whether genetic fatalism affects sun-related health behaviours in high-risk individuals. University of Queensland $327,192
Partnerships Prof H. Peter Soyer Implementation of an innovative teledermatology network for the early detection of melanoma in high risk Australians University of Queensland $1,195,649
Development Grants *Dr Michelle Wykes Development of a novel PDL2-based immune therapy for cancer QIMR Berghofer $583,765
Development Grants Dr Glen Boyle The development of Tigilanol Tiglate as a neo-adjuvant in immuno-oncology QIMR Berghofer $657,521
Project Grants Dr Glen Boyle Defining heterogeneous co-operativity in melanoma invasion and metastasis QIMR Berghofer $615,488
Project Grants Dr Katja Fischer NOVEL DRUGS TO REDUCE THE HUMAN SCABIES BURDEN QIMR Berghofer $1,368,860
Project Grants A/Pr Kiarash Khosrotehrani Targeting the pre-metastatic vascular niche in melanoma using a novel molecular strategy University of Queensland $843,857


* ASSC members, but specific projects/fellowships are targeting several different subject areas.

The full results of the 2018 NHMRC funding round can be view online.

The results form part of $18 million secured by researchers at The University of Queensland Faculty of Medicine and almost $11 million by QIMR Berghofer Medical Research Institute in the latest round of National Health and Medical Research Council (NHMRC) funding.

Media: Melissa Kerr,, +61 7 3443 7395